Utility loss and indirect costs after stroke in Sweden

European Journal of Preventive Cardiology

Volumn 15, Issue 2, 2008, Pages 230-233

  Lindgren, Peter ^a,b   Glader, Eva Lotta ^d   Jönsson, Bengt ^c  

^a i3 Innovus   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

indirect costs; quality of life; stroke; Sweden; utility

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; EMPLOYER; EMPLOYMENT STATUS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; REGRESSION ANALYSIS; SALARY; SCORING SYSTEM; STROKE; SWEDEN;

AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RECOVERY OF FUNCTION; SALARIES AND FRINGE BENEFITS; SICK LEAVE; STROKE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 41949138967     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f37a22     Document Type: Article

References (17)

1. Pharmaceutical Benefits Board, General guidelines for economicevaluation from the Pharmaceutical Benefits Board. 2003: Stockholm.
2. National Institute of Clinical Excellence, Guide to the Methods ofTechnology Appraisals. 2004: London.
3. Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates forstroke. Pharmacoeconomics 2003; 21: 191–200.
4. Lindgren P, Kahan T, Poulter N, Buxton M, Svarvar P, Dahlof B, et al Utility loss and indirect costs following cardiovascular eventsin hypertensive patients: the ASCOT health economicsubstudy. Eur J Health Econ 2006; 8: 25–30.
5. Suenkeler IH, Nowak M, Misselwitz B, Kugler C, Schreiber W, Oertel WH, et al Timecourse of health-related quality of life as determined 3, 6and 12 months after stroke. Relationship to neurological deficit, disabilityand depression. J Neurol 2002; 249: 1160–1167.
6. Jonsson AC, Lindgren I, Hallstrom B, Norrving B, Lindgren A. Determinants of quality of life in stroke survivors and theirinformal caregivers. Stroke 2005; 36: 803–808.
7. Ghatnekar O, Persson U, Glader EL, Terent A. Cost of stroke in Sweden: an incidence estimate. Int J Technol Assess Health Care 2004; 20: 375–380.
8. Zethraeus N, Molin T, Henriksson P, Jonsson B. Costs of coronary heart disease and stroke: the case ofSweden. J Intern Med 1999; 246: 151–159.
9. Asplund K, Hulter Åsberg K, Norrving B, Stegmayr B, Terént A, Wester P, et al Riks-Stroke: a Swedish national quality register for strokecare. Cerebrovasc Dis 2003; 15(Suppl):5–7.
10. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53–72.
11. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095–1108.
12. Statistics Sweden. Labour market statistics. 2006; Available from: www.scb.se.
13. Powell J. Least absolute deviations estimation for the censored regressionmodel. J Econometrics 1984; 25: 303–325.
14. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman&Hall/CRC; 1993.
15. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results usingthe EQ-5D. Qual Life Res 2001; 10: 621–635.
16. Burstrom K, Johannesson M, Diderichsen F. Health-related quality of life by disease and socio-economicgroup in the general population in Sweden. Health Policy 2001; 55: 51–69.
17. Burstrom K, Johannesson M, Diderichsen F. A comparison of individual and social time trade-off values forhealth states in the general population. Health Policy 2006; 76: 359–370.